Xilam: H1 2018 Revenue: +50%
The Xilam Group (Paris:XIL) posted consolidated H1 2018 revenue of EUR 13,866 thousand, an increase of 50%. This increase represents an excellent performance, as it follows on the heels of growth of 54% in H1 2017. Revenue for the first part of this financial year breaks down as follows.
|In thousands of euros||30.06.2018 (1)||30.06.2017||
|Revenue and subsidies||13,866||9,239||+50%|
(1) Unaudited data.
Remarkable success for new releases +85%
Excellent H1 growth was driven by the two main businesses, New Productions and Catalogue.
In New Productions, H1 deliveries generated record revenue of EUR 8,465 thousand, an 85% increase compared with H1 2017, and confirmed Xilam’s position as a major European animation company.
Catalogue revenue was up 16% compared with H1 2017, thanks again to traditional TV channels and digital platforms, in both France and abroad.
A fast-paced delivery schedule
Thanks to its increasing production capacity in recent years, Xilam delivered 37 half-hour programmes over the half year, and has thus completed production of all episodes of:
- the fifth season of Oggy & the Cockroaches , which has notably been pre-purchased by Gulli in France, and Cartoon Network and Netflix internationally; this season is already ranked among the top audience figures of the main broadcasters associated with the brand;
- Paprika , the Group’s first preschool show, which has been pre-purchased by France Télévisions, Disney Channel and Netflix; Initial launches in France, Italy and Australia are already very promising.
- The second season of Magic , pre-purchased by Gulli in France, Discovery and Amazon internationally, which will be launched at the end of the year.
- If I were an animal , a wildlife series designed especially for children, pre-purchased notably by France Télévisions and Netflix, and for which international pre-sales point to excellent longevity as a catalogue property.
A well-furnished catalogue which has again provided record catalogue revenue
H1 saw yet another historical performance for the catalogue, with sales up a further 16%.
YouTube income rocketed 73%, driven by almost 1.9 billion video views over the period, confirming Xilam’s position among the leading animated content providers on the largest global streaming platform.
This growth was mainly due to the success of Oggy & the Cockroaches and Zig & Sharko , with the number of video views for the latter now equalling that of Oggy & the Cockroaches .
The Group’s other content also contributed to sales growth in France, Italy and India, such as the two seasons of The Daltons .
Record sales expected in 2018
After this successful H1, the delivery of new productions will continue in H2 at a rapid rate, and catalogue sales are expected to enjoy a fresh increase, thus confirming continued robust growth.
Mr. Magoo, Zig & Sharko 3, Coach me if you can : expected global success
H2 will see the delivery of the first episodes of Mr. Magoo , Zig & Sharko 3 and Coach me if you can :
- Mr. Magoo , based on the famous American character from the 1950s (which won several Oscars), has already broken Xilam’s all-time pre-sale record, as its broadcast is already guaranteed in at least 150 countries.
- The keenly awaited and widely pre-purchased season three of Zig & Sharko , should again ensure the content’s strength worldwide, placing Zig & Sharko side by side with Oggy & the Cockroaches .
- Coach me if you can : an original, football-themed creation from the Xilam studio that is expected to be released worldwide and will be gradually launched at the end of 2019 to be fully broadcast to coincide with Euro 2020.
In view of this highly favourable outlook, Xilam is confident in its ability to post further record-breaking results for the financial year as a whole.
Xilam is also currently working on Tiny Bad Wolf (a new preschool series) and The Fabulous Adventures of Prince Moka (a new comedy), confirming its target of delivering 100 half-hour programmes per year as of 2020.
Xilam thus confirms its growing ability to create, produce and distribute high-quality animated programmes and market them at an increasingly rapid rate on the world’s largest global broadcasting platforms, providing these programmes, which it fully owns, with an excellent long-term asset value.
NB: The Group has adopted IFRS 15 - Revenue from Contracts with Customers, and this document therefore presents 2018 revenue after the application of this new standard. Using the same revenue recognition method as in 2017, H1 2018 revenue would have been EUR 8,094 thousand for New Productions and EUR 4,771 thousand for the Catalogue business. As the Group has opted for the cumulative recovery method, H1 2018 and FY 2018 financial statements will be restated in the notes to the financial statements for the effects of the application of this new standard.
Xilam is one of Europe’s leading animation companies, creating, producing and distributing original children’s and family entertainment content across TV, film and digital media platforms.
Founded in 1999 by Marc du Pontavice, Xilam owns a catalogue of more than 2,000 animated episodes and three feature films including strong brands such as Oggy & the Cockroaches, Zig & Sharko, The Daltons and its first pre-school series, Paprika.
Broadcast in over 190 countries on all the major TV networks and digital platforms, including YouTube with over 300 million video views monthly, Xilam’s programme catalogue makes the company one of the top global content providers in animation.
Xilam employs more than 400 people, including 300 artists, who are based across its four studios located in Paris, Lyon, Angoulême and Ho-Chi-Minh City in Vietnam.
Xilam is listed on Compartment B of Euronext Paris
ISIN code: FR0004034072 / Ticker: XIL
Marc du Pontavice – Chairman and CEO
François Bardoux – CFO
Tel: +33 1 40 18 72 00
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
China National Medical Products Administration (NMPA) Approves Gilead’s Vemlidy® (Tenofovir Alafenamide) for Chronic Hepatitis B Virus (HBV) Infection19.11.2018 03:00 | Pressemelding
Gilead Sciences, Inc. (NASDAQ: GILD) announced today that the China National Medical Products Administration (NMPA) has approved Vemlidy® (tenofovir alafenamide, TAF) 25 mg, a once-daily treatment for chronic hepatitis B in adults and adolescents (aged 12 years and older with body weight at least 35 kg). Vemlidy is a novel, targeted prodrug of tenofovir that has demonstrated antiviral efficacy similar to Gilead’s Viread® (tenofovir disoproxil fumarate, TDF) 300 mg but at one-tenth of the dose. Data show that because Vemlidy has greater plasma stability and more efficiently delivers tenofovir to hepatocytes compared to Viread, it can be given at a lower dose, resulting in less tenofovir in the bloodstream. In clinical trials, Vemlidy demonstrated improved renal and bone laboratory safety parameters compared to Viread. “With the approval of Vemlidy, physicians can now offer their patients a treatment that retains the efficacy of TDF while improving renal and bone safety parameters in cli
Celltrion Healthcare: Biosimilars Have the Potential to Deliver Dramatic Cost Savings for US and European Healthcare Systems19.11.2018 00:01 | Pressemelding
Celltrion Healthcare outlined their vision of ‘shaping future healthcare by improving access to biosimilars’ at the 5th Annual Biosimilars USA Conference in New Jersey, US. Biosimilars offer healthcare providers and patients greater treatment choice and value, better access to treatments and improved patient outcomes. According to data provided by IMS Health, biosimilars could lead to cumulative savings of up to 107 billion USD by 2020 in the United States (US) and the top five European Union (EU) countries.1 The EU has made significant progress in unlocking the potential of biosimilars through continuous education of providers, payers and patients. This has been critical to EU biosimilar acceptance but has not been seen in the US, which has lagged behind. During a presentation on the opportunities and challenges presented by the use of biosimilars in the US, Celltrion Healthcare highlighted several challenges affecting the uptake of biosimilars within the US market. Both physicians an
Abu Dhabi to Host Interfaith Alliance For Safer Communities: Child Dignity in the Digital World Forum on 19 November17.11.2018 13:40 | Pressemelding
Held under the patronage of His Highness Sheikh Mohammed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces, the UAE will host the first edition of the Interfaith Alliance For Safer Communities Forum on November 19-20 in recognition of the country’s leading role in promoting tolerance and interfaith dialogue. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181117005008/en/ His Highness Sheikh Mohammed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces (Photo: AETOSWire) The forum will host 450 guests including religious leaders, NGOs and heads of industry to discuss ongoing social challenges and develop comprehensive solutions for protecting youth from cybercrime. The Interfaith Alliance For Safer Communities Forum is an expansion of the Child Dignity in the Digital World Congress which was held in October 2017 in the Vatican, an
Philip Morris International and Dorna Switch Gears in Quest for a World without Tobacco Smoke17.11.2018 11:00 | Pressemelding
Philip Morris International Inc. (PMI) (NYSE:PM) and Dorna Sports S.L., the commercial rights holder for the world FIM MotoGP Championships, have extended their partnership until the end of 2021. The two organizations have collaborated successfully for 26 years. As of 2019, the partnership will focus on advancing the cause of a smoke-free world. More than 1 billion people smoke today and, according to the World Health Organization, will continue to smoke in the near future. PMI has committed to transform its business and encourage all men and women who would otherwise continue smoking to replace cigarettes with better alternatives as soon as possible. With around 350 million MotoGP fans worldwide, MotoGP can play a significant role in positively impacting the lives of people who smoke and those around them. “The best choice for consumers concerned about the health risks of smoking is to quit tobacco and nicotine altogether. Today, however, technology, science and innovation provide a r
Schlumberger Announces Fourth-Quarter and Full-Year 2018 Results Conference Call16.11.2018 18:00 | Pressemelding
Schlumberger Limited (NYSE:SLB) will hold a conference call on January 18, 2019 to discuss the results for the fourth quarter and full year ending December 31, 2018. The conference call is scheduled to begin at 8:30 am US Eastern time and a press release regarding the results will be issued at 7:00 am US Eastern time. To access the conference call, listeners should contact the Conference Call Operator at +1 (800) 288-8967 within North America or +1 (612) 333-4911 outside of North America approximately 10 minutes prior to the start of the call, and ask for the “Schlumberger Earnings Conference Call.” A webcast of the conference call will be broadcast simultaneously at www.slb.com/irwebcast on a listen-only basis. Listeners should log in 15 minutes prior to the start of the call to test their browsers and register for the webcast. Following the end of the conference call, a replay will be available at www.slb.com/irwebcast until February 18, 2019, and can be accessed by dialing +1 (800)
Visa Strengthens Commitment to Growing Digital Payments in India16.11.2018 14:33 | Pressemelding
Visa (NYSE: V) today announced a minority investment in BillDesk, a leading platform for online payments and bill payments in India. Visa’s investment and collaboration will help BillDesk develop new product lines for its payments and loyalty businesses and also expand its footprint into other geographies. The investment will be subject to necessary statutory approvals and is expected to have no direct bearing on Visa’s existing Indian business. “As a leading payments player in India, BillDesk has been a long time business partner to Visa. Having worked with BillDesk’s founders over the years, the Visa leadership has been consistently impressed with their vision, market knowledge and execution capabilities, as well as alignment on values. This investment further reinforces our long-term commitment to India’s digital payments growth story,” said Asia Pacific regional president, Chris Clark. “We are truly excited by this investment from the world's largest global payment network, Visa. W